The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma

R.L.G.M. Blom (1) , W.M.J. Schreurs (2) , H.J. Belgers (1) , L.E. Oostenbrug (3) , R.F.A. Vliegen (4) , M.N. Sosef (1)

1 Department of Surgery
2 Department of Nuclear Medicine
3 Department of Internal Medicine and Gastroenterology
4 Department of Radiology

PET-CT scanning is increasingly applied in the primary work-up of esophageal cancer patients. The additional value of a second PET-CT after completion of neoadjuvant therapy (NT) prior to surgery is presently unclear. Therefore, a consecutive series of esophageal cancer patients underwent PET-CT scanning after completion of NT for evaluation of metastatic disease that became manifest under NT.

Mots clés: PET-CT; interval metastases; esophageal carcinoma; neoadjuvant therapy; diagnosis

R.L.G.M. Blom, W.M.J. Schreurs, H.J. Belgers, L.E. Oostenbrug, R.F.A. Vliegen, et al.. The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma. EJSO - European Journal of Surgical Oncology, 2011, 37 (9), pp.774. ⟨10.1016/j.ejso.2011.06.002⟩. ⟨hal-00723461⟩